Increased chemokine gene expression during aging in the murine brain

L K Felzien1, J T McDonald, S M Gleason

  • 1Department of Anatomy and Cell Biology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA. lisa.felzien@rockhurst.edu

Brain Research
|February 13, 2001
PubMed

Insights

Brain aging leads to cognitive decline. This study found increased chemokine expression and microglial activation in aging mouse brains, suggesting a link to memory loss.

Area of Science:

  • Neuroscience
  • Immunology
  • Aging Research

Background:

  • Normal brain aging is associated with functional decline, particularly in learning and memory.
  • The underlying mechanisms of age-related cognitive decline remain unclear.
  • Microglial activation, a component of the aging process, can produce detrimental substances.

Purpose of the Study:

  • To investigate changes in chemokine gene expression during normal aging in the mouse brain.
  • To determine if specific chemokines are upregulated in aging brains.
  • To correlate chemokine expression with microglial activation.

Main Methods:

  • Gene expression analysis (RNase protection assays) of mouse brain regions (cortex, midbrain, hippocampus, cerebellum) at different ages (4, 10, 21, 30 months).
  • Protein level quantification using ELISA.
  • Immunohistochemistry with F4/80 antibodies to assess microglial activation.

Main Results:

  • Significant increases in macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES gene expression were observed in all brain regions of the oldest mice (30 months).
  • These chemokine increases were detectable starting at 21 months of age.
  • Elevated protein levels of these chemokines and increased microglial activation were confirmed in aged brains.

Conclusions:

  • Chemokine gene expression, specifically MIP-1alpha, MIP-1beta, and RANTES, is upregulated during normal mouse brain aging.
  • Increased microglial activation correlates with elevated chemokine levels in aging brains.
  • These findings suggest that chemokines may play a role in age-related cognitive decline.

Related Concept Videos